2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced that Dr. Eric von Hofe, PhD, an executive with the company's Antigen Express subsidiary, has been appointed as the company's vice president in charge of product development and scientific affairs.
"We are pleased that Dr. von Hofe has agreed to assume this important role on our team," said Anna Gluskin, the company's president and CEO. "In conjunction with our on-going implementation of the global clinical and regulatory program for Oralin, Dr. von Hofe will spearhead the development of other applications of our proprietary oral-spray formulation drug-delivery technology such as …
No comments:
Post a Comment